American Portfolios Advisors’s Standard BioTools LAB Stock Holding History

American Portfolios Advisors’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-350	Closed	-$1.26K	–	3590
2022 Q1	$1.26K	Hold	350	–	–	﹤0.01%	3319
2021 Q4	$1.37K	Sell	350 -200	-36%	-$936	﹤0.01%	3264
2021 Q3	$3.63K	Sell	550 -800	-59%	-$5.26K	﹤0.01%	2970
2021 Q2	$8.32K	Hold	1,350	–	–	﹤0.01%	2604
2021 Q1	$6.1K	Hold	1,350	–	–	﹤0.01%	2622
2020 Q4	$8.1K	Hold	1,350	–	–	﹤0.01%	2210
2020 Q3	$10K	Sell	1,350 -2,350	-64%	-$16.2K	﹤0.01%	1976
2020 Q2	$14.8K	Buy	+3,700	New	+$12.9K	﹤0.01%	1772

Other funds holding LAB

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Portfolios Advisors's LAB Position: Q2 2022 in Review

American Portfolios Advisors sold out of Standard BioTools (LAB) in Q2 2022, closing a stake of 350 shares — an estimated $1.26K sold.

American Portfolios Advisors first reported a position in LAB in Q2 2020 and held it in 8 quarters. The position peaked at $14.8K in Q2 2020. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2022.

American Portfolios Advisors reported no remaining Standard BioTools position as of Q2 2022 after selling out during the quarter.
American Portfolios Advisors sold 350 Standard BioTools shares in Q2 2022, an estimated $1.26K.
American Portfolios Advisors first reported a position in Standard BioTools in Q2 2020 and held it in 8 quarters.
American Portfolios Advisors's Standard BioTools position peaked at $14.8K in Q2 2020.
86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2022.

Based on American Portfolios Advisors's 13F filing for Q2 2022, filed 20 Mar 2023.